HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Gordon, P V Articles by Fox, N S Search for Related Content PubMed PubMed Citation Articles by Gordon, P V Articles by Fox, N S

Department of Pediatrics, Division of Neonatology, University of Virginia Health Sciences, PO Box 800386, Charlottesville, Virginia 22908, USA
¹ Department of Microbiology, University of Virginia Health Sciences, PO Box 800734, Charlottesville, Virginia 22908, USA

(Requests for offprints should be addressed to P V Gordon; Email: pvg4n{at}virginia.edu)

Glucocorticoids induce hypertrophy of the neonatal ileal mucosa but the molecular mechanisms behind this growth induction remain poorly understood. Ileal epithelial cells (IECs) are dependent upon IGF-II for proliferation both in vivo and in culture. The type-2 IGF receptor (IGFR-2) is a lysosomal transport protein that attenuates IGF-II-driven growth and is highly abundant in the ileum. The cellular repressor of E1A-stimulated genes (CREG) is a secreted phosphoglycoprotein that affects cell fate via ligand binding with IGFR-2, although the mechanism by which it does so is unknown. We hypothesized that glucocorticoids might facilitate IGF-mediated hypertrophy through CREG-mediated degradation of IGFR-2. To test this hypothesis, confluent rat IECs (IEC-18) were cultured for 72 h with or without dexamethasone (DEX) and harvested for Western blot, immunocytochemistry, gene array and CREG immunoneutralization experiments. IGFR-2 and CREG immunohistochemistry were also performed in archived ileal specimens from control and DEX-exposed newborn mice and extremely premature infants to investigate in vivo and clinical relevance. DEX exposure was found to diminish IGFR-2 immunolocalization in cultured rat IECs, newborn mouse ileal mucosa and human neonatal ileal mucosa. Gene array data indicated that IGFR-2 expression was unchanged with DEX treatment, suggesting a mechanism of protein degradation. CREG immunolocalization and abundance was found to be increased by DEX and immunoneutralization of CREG resulted in the abolition of IGFR-2 degradation. We have concluded that CREG is a secreted mediator by which DEX induces degradation of IGFR-2 and speculate that this is a fundamental mechanism of mucosal growth induction.

This article has been cited by other articles:

				Y.-L. Han, P. Guo, M.-Y. Sun, L. Guo, B. Luan, J. Kang, C.-H. Yan, and S.-H. Li Secreted CREG inhibits cell proliferation mediated by mannose 6-phosphate/insulin-like growth factor II receptor in NIH3T3 fibroblasts Genes Cells, September 1, 2008; 13(9): 977 - 986. [Abstract] [Full Text] [PDF]

				M. Sacher, A. Di Bacco, V. V. Lunin, Z. Ye, J. Wagner, G. Gill, and M. Cygler The crystal structure of CREG, a secreted glycoprotein involved in cellular growth and differentiation PNAS, December 20, 2005; 102(51): 18326 - 18331. [Abstract] [Full Text] [PDF]